KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $862,359 | -63.8% | 5,100 | -53.6% | 0.00% | -71.4% |
| Q2 2023 | $2,385,350 | -34.2% | 11,000 | -44.9% | 0.01% | -12.5% |
| Q1 2023 | $3,625,898 | -44.7% | 19,962 | -40.2% | 0.01% | -57.9% |
| Q4 2022 | $6,557,402 | -11.8% | 33,371 | +0.9% | 0.02% | -17.4% |
| Q3 2022 | $7,436,000 | +7.4% | 33,058 | -39.6% | 0.02% | 0.0% |
| Q2 2022 | $6,924,000 | +212.7% | 54,723 | +213.4% | 0.02% | +228.6% |
| Q1 2022 | $2,214,000 | +106.0% | 17,459 | +112.9% | 0.01% | +133.3% |
| Q4 2021 | $1,075,000 | +326.6% | 8,200 | +290.5% | 0.00% | +200.0% |
| Q1 2021 | $252,000 | -82.3% | 2,100 | -85.0% | 0.00% | -83.3% |
| Q4 2020 | $1,423,000 | +611.5% | 14,000 | +677.8% | 0.01% | +500.0% |
| Q2 2020 | $200,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |